Year: 2024
Type: conference-paper
Abstract: Glioblastomas (GBs) are aggressive brain tumors with limited treatment options, where surgery, radiotherapy (RXT), and chemotherapy (CMT) offer marginal survival benefits. The economic and healthcare system's role in GB treatment, particularly in developing countries, highlights disparities in patient outcomes and challenges in providing appropriate care.
DOI: 10.56238/i-cim-082
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4405154540
